Respiratory Nutrition Micronutrients NICU Growth and development Immunization Complementary feeding Breastfeeding and lactation Cerebral palsy Learning disorders Fe deficiency Anemia

Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I've reached the query_library_db limit. The library searches returned minimal results, so I'll now provide a comprehensive, authoritative answer from my medical knowledge across all 11 pediatric/neonatology topics.

Pediatrics & Neonatology: Comprehensive Topic Guide


1. Respiratory (Pediatric)

Key Conditions

Respiratory Distress Syndrome (RDS) / Hyaline Membrane Disease
  • Most common cause of respiratory distress in preterm neonates (<37 weeks), especially <34 weeks
  • Pathophysiology: surfactant deficiency → alveolar collapse → ↑ work of breathing, hypoxemia, hypercarbia
  • Clinical features: tachypnea, grunting, nasal flaring, subcostal/intercostal retractions, cyanosis within 6 hours of birth
  • CXR: ground-glass opacity, air bronchograms, "white-out" in severe cases
  • Management:
    • Antenatal corticosteroids (betamethasone 12 mg IM × 2 doses, 24h apart) if 24–34 weeks gestation
    • Exogenous surfactant (beractant, poractant alfa) — intratracheal
    • CPAP or mechanical ventilation
    • Oxygen — target SpO₂ 91–95% in preterms
Transient Tachypnea of the Newborn (TTN)
  • Most common respiratory disorder in term neonates
  • Caused by delayed resorption of fetal lung fluid (especially after C-section)
  • Self-limiting within 12–72 hours
  • CXR: wet silhouette, perihilar streaking, fluid in fissures
Meconium Aspiration Syndrome (MAS)
  • Seen in post-term or stressed term infants
  • Pathophysiology: meconium in amniotic fluid → aspiration → ball-valve obstruction, pneumonitis, pulmonary hypertension
  • Management: suctioning, surfactant, inhaled NO for pulmonary hypertension, ECMO in refractory cases
Bronchiolitis
  • Most common lower respiratory tract infection in infants <2 years
  • Most common cause: RSV (Respiratory Syncytial Virus)
  • Features: rhinorrhea → cough → wheeze/crackles → respiratory distress
  • Management: supportive — oxygen, hydration, high-flow nasal cannula
  • Palivizumab: RSV prophylaxis for high-risk infants (preterms <29 weeks, CLD, congenital heart disease)
Pneumonia
  • Neonatal: GBS, E. coli, Listeria (early-onset); Staph aureus, Klebsiella (late-onset)
  • Infants 1–3 months: Chlamydia trachomatis (staccato cough, no fever, eosinophilia)
  • Toddlers/preschool: viral (RSV, parainfluenza, rhinovirus)
  • School age+: Mycoplasma pneumoniae ("walking pneumonia")
Cystic Fibrosis (CF)
  • Autosomal recessive, CFTR mutation (ΔF508 most common)
  • Features: recurrent pulmonary infections, pancreatic exocrine insufficiency, failure to thrive, meconium ileus in neonates, salty sweat
  • Diagnosis: newborn screening (IRT), sweat chloride test >60 mmol/L
  • Management: physiotherapy, CFTR modulators (ivacaftor, elexacaftor-tezacaftor-ivacaftor), enzyme replacement, antibiotics

2. Nutrition (Pediatric)

Caloric Requirements

Agekcal/kg/day
Preterm NICU100–130
0–6 months100–110
6–12 months80–100
1–3 years80–90
4–6 years70–80

Macronutrients

  • Protein: 3–4 g/kg/day (preterm), 1.5–2 g/kg/day (term infant)
  • Fat: 50% of calories in breast milk; essential fatty acids (DHA, ARA) critical for brain development
  • Carbohydrates: lactose primary source in infants

Routes of Feeding

  • Enteral nutrition preferred whenever gut is functional
  • Parenteral nutrition (PN): for preterm or ill neonates unable to tolerate enteral feeds
    • Provides glucose, amino acids, lipid emulsions (Intralipid), electrolytes, trace elements
    • Complications: catheter-related sepsis, cholestasis, hyperglycemia

Malnutrition

  • Protein-Energy Malnutrition (PEM):
    • Kwashiorkor: protein deficiency, edema, hair changes (flag sign), dermatitis, preserved fat stores, fatty liver
    • Marasmus: total caloric deficiency, severe wasting, no edema, very low weight, alert facies
  • WHO management: RUTF (Ready-to-Use Therapeutic Food), 10 steps of nutritional rehabilitation

3. Micronutrients

Vitamin A

  • Deficiency: xerophthalmia (night blindness → Bitot spots → corneal ulceration → keratomalacia), increased susceptibility to infections
  • Supplementation: given at 6, 12, and 18 months in deficiency-endemic areas
  • Measles complication: high-dose Vitamin A supplementation (200,000 IU) reduces morbidity/mortality

Vitamin D

  • Deficiency → Rickets (nutritional): bowed legs, rachitic rosary, widened wrists, Harrison's groove, craniotabes
  • Diagnosis: low 25-OH Vitamin D, low Ca²⁺/PO₄, elevated ALP and PTH
  • Treatment: Vitamin D₃ 2,000–4,000 IU/day + calcium supplementation
  • All breastfed infants: 400 IU/day Vitamin D supplement from birth

Vitamin C

  • Deficiency → Scurvy: perifollicular hemorrhages, corkscrew hairs, bleeding gums, subperiosteal hemorrhage, Frankel lines on X-ray

Vitamin K

  • Deficiency → Hemorrhagic Disease of Newborn (Vitamin K Deficiency Bleeding, VKDB)
    • Early (0–24h): maternal drugs (anticonvulsants, warfarin)
    • Classic (2–7 days): breastfed, no prophylaxis
    • Late (2–12 weeks): fat malabsorption, cholestasis
  • Prevention: Vitamin K 1 mg IM at birth (0.5 mg if <1,500 g)

Iron (Fe)

  • See topic 11 below

Iodine

  • Deficiency: congenital hypothyroidism, cretinism (intellectual disability, goiter, stunted growth, deafness)
  • Universal salt iodization is primary prevention strategy

Zinc

  • Deficiency: impaired wound healing, diarrhea, alopecia, acrodermatitis enteropathica (autosomal recessive, failure to absorb zinc)
  • Critical for immune function and growth

Folate

  • Deficiency in pregnancy → neural tube defects (spina bifida, anencephaly)
  • Supplementation: 400–800 µg/day periconceptionally

4. NICU (Neonatal Intensive Care Unit)

Admission Criteria

  • Prematurity <34 weeks, birth weight <1,500 g (VLBW) or <1,000 g (ELBW)
  • Respiratory distress, apnea of prematurity
  • Neonatal sepsis, meconium aspiration, birth asphyxia
  • Surgical conditions (NEC, CDH, esophageal atresia)

Key NICU Problems

Apnea of Prematurity
  • Cessation of breathing >20 seconds or shorter with bradycardia/desaturation
  • Types: central (no respiratory effort), obstructive (effort but no airflow), mixed (most common)
  • Management: methylxanthines (caffeine citrate — drug of choice), CPAP, tactile stimulation
  • Caffeine: reduces need for mechanical ventilation, associated with improved neurodevelopmental outcomes
Intraventricular Hemorrhage (IVH)
  • Common in VLBW/ELBW preterms
  • Grading (Papile classification):
    • Grade I: germinal matrix only
    • Grade II: IVH without ventricular dilation
    • Grade III: IVH with ventricular dilation
    • Grade IV: periventricular hemorrhagic infarction (worst prognosis)
  • Screening: cranial ultrasound day 3–5 and day 7–10
  • Prevention: antenatal steroids, Vitamin K, indomethacin (prophylactic)
Necrotizing Enterocolitis (NEC)
  • Most common GI surgical emergency in neonates
  • Risk factors: prematurity, formula feeding, hypoxia, polycythemia
  • Bell's staging:
    • Stage I: suspected (clinical signs, normal/nonspecific X-ray)
    • Stage II: confirmed (pneumatosis intestinalis on X-ray)
    • Stage III: advanced (perforation — pneumoperitoneum)
  • Management: NPO, NG decompression, broad-spectrum antibiotics, surgical resection for perforation/necrosis
  • Prevention: breast milk, probiotic supplementation
Neonatal Jaundice / Hyperbilirubinemia
  • Physiological: starts day 2–3, peaks day 4–5, resolves by day 10 (term) or day 14 (preterm)
  • Pathological: starts <24 hours, rises >5 mg/dL/day, direct bilirubin >2 mg/dL
  • Causes: hemolytic (ABO/Rh incompatibility, G6PD), sepsis, metabolic
  • Management: phototherapy (AAP curves by gestational age/age in hours), exchange transfusion
Retinopathy of Prematurity (ROP)
  • Abnormal retinal vascularization in preterms (<32 weeks, <1,500 g)
  • Zonal classification (I, II, III) and staging (1–5)
  • Plus disease: vascular dilation + tortuosity
  • Screening: dilated fundus exam at 4–6 weeks of age
  • Treatment: laser photocoagulation, anti-VEGF (bevacizumab)
Hypothermia / Thermoregulation
  • Neonates: poikilothermic, high surface area:mass ratio → rapid heat loss
  • Methods of heat loss: radiation, convection, conduction, evaporation
  • Management: radiant warmer, incubator, skin-to-skin (kangaroo care)
  • Therapeutic hypothermia: for HIE (hypoxic-ischemic encephalopathy) ≥36 weeks, initiated within 6 hours of birth, target 33–34°C for 72 hours
Neonatal Hypoglycemia
  • Threshold: blood glucose <47 mg/dL (symptomatic) or <40 mg/dL (neonatal)
  • Risk groups: IDM, SGA, preterm, macrosomic infants
  • Symptoms: jitteriness, seizures, apnea, hypotonia, lethargy
  • Management: early enteral feeding, IV dextrose (D10W 2 mL/kg bolus → infusion)
Neonatal Sepsis
  • Early-onset (<72h): GBS, E. coli, Listeria — acquire intrapartum
  • Late-onset (>72h): coagulase-negative Staph, Staph aureus, Gram-negative rods
  • Workup: CBC, CRP, blood culture, LP (if stable), urine culture
  • Empirical treatment: ampicillin + gentamicin (early); vancomycin + aminoglycoside (late)

5. Growth and Development

Physical Growth

Weight
  • Birth weight: average 3.0–3.5 kg
  • Physiological weight loss 7–10% in first week (regained by day 10–14)
  • Doubles by 5 months, triples by 12 months
  • 4–6 years: +2 kg/year
Length/Height
  • Birth: 50 cm → 75 cm by 12 months → 100 cm by 4 years
  • Pubertal growth spurt: girls ~10–11 years, boys ~12–13 years
Head Circumference (OFC)
  • Birth: 33–35 cm → +12 cm in first year (half of postnatal growth)
  • Anterior fontanelle closes: 9–18 months
  • Posterior fontanelle closes: 6–8 weeks

Developmental Milestones

AgeGross MotorFine MotorLanguageSocial
2 moHead control proneHands unfistedSocial smile, coosRecognizes face
4 moRolls front-to-backReach, graspLaughs, vowelsResponds to voice
6 moSits with supportTransfers hand-to-handBabblesStranger anxiety begins
9 moCruises, crawlsPincer grasp developing"Mama/dada" non-specificallyObject permanence
12 moWalks independentlyMature pincer1–3 words with meaningWaves bye
18 moRunsStacks 4 cubes10–20 wordsParallel play
24 moClimbs stairs (2 feet/step)Stacks 6 cubes50+ words, 2-word phrasesParallel play
3 yrRides tricycleCopies circle3-word sentencesGroup play
4 yrHops on one footCopies cross4-word sentencesCooperative play
5 yrSkipsCopies triangleFull sentences

Denver Developmental Screening Test (DDST)

  • Screens personal-social, fine motor-adaptive, language, gross motor
  • Not diagnostic — identifies children needing further evaluation

Red Flags (Developmental)

  • No social smile by 3 months
  • No head control by 4 months
  • Not sitting unsupported by 9 months
  • No words by 16 months, no 2-word phrases by 24 months
  • Any regression of milestones at any age

6. Immunization (Pediatric)

EPI Schedule (India / WHO-based)

AgeVaccine
BirthBCG, OPV-0, Hepatitis B-1
6 weeksDTP-1, IPV-1, Hep B-2, Hib-1, PCV-1, Rotavirus-1
10 weeksDTP-2, IPV-2, Hib-2, PCV-2, Rotavirus-2
14 weeksDTP-3, IPV-3, Hib-3, PCV-3, Rotavirus-3
6 monthsOPV-1, Hep B-3
9 monthsMR/MMR-1, Vitamin A-1
12 monthsHep A-1
15–18 monthsDTP booster-1, OPV-3, MMR-2, Varicella, Hep A-2
2 yearsTyphoid conjugate vaccine (annual)
5 yearsDTP booster-2
10–12 yearsTd, HPV (girls)

Key Points

  • BCG: given at birth, protects against disseminated TB, tuberculosis meningitis; Mantoux test may be positive after BCG
  • OPV vs IPV: OPV — live attenuated (oral, cheap, herd immunity, risk of VAPP); IPV — inactivated (injectable, no VAPP risk, preferred in India now)
  • Cold chain: vaccines stored at 2–8°C (freeze-sensitive: DTP, Hep B, Hib, PCV; freeze-tolerant: OPV, MMR, BCG)
  • Contraindications: live vaccines contraindicated in immunocompromised (except HIV with CD4 >25%); MMR contraindicated in egg allergy (anaphylaxis) — actually safe in egg allergy; contraindicated in pregnancy
  • Vaccine adverse events: BCG adenitis, febrile seizures post-MMR (day 7–12), intussusception risk post-rotavirus, anaphylaxis

7. Complementary Feeding

Definition

Introduction of solid/semi-solid foods alongside breast milk or formula, beginning at 6 months of age.

WHO Recommendations

  • Exclusive breastfeeding for first 6 months
  • Complementary feeding introduced at exactly 6 months (not before 4 months)
  • Continue breastfeeding up to 2 years or beyond

IYCF Principles (Infant and Young Child Feeding)

  • Timely: start at 6 months
  • Adequate: sufficient in quantity, quality, nutrient density
  • Safe: hygienic preparation, safe storage
  • Appropriately fed: responsive feeding, appropriate texture by age

Feeding Progression

AgeTextureFrequencyAmount
6–8 monthsPurée/mashed2–3 times/day2–3 tsp → gradually increase
9–11 monthsFinely chopped, mashed3–4 times/day½ cup (125 mL)
12–24 monthsFamily foods, chopped3–4 times/day + snacks¾ cup (175 mL)

What to Introduce

  • Staples (rice, wheat, maize), legumes, vegetables, fruits, animal source foods (meat, egg, fish, dairy)
  • Iron-rich foods early (meat, fortified cereals) — critical given iron stores deplete after 6 months
  • No added salt, sugar, honey (honey: risk of infant botulism <1 year)
  • No cow's milk as main drink before 12 months (may be used in cooking)

Common Mistakes

  • Early introduction (<4 months): ↑ risk of allergy, obesity, celiac disease
  • Late introduction (>6 months): ↑ risk of iron deficiency, stunting
  • Low nutrient density foods: watery porridges (energy-poor)
  • Improper hygiene: diarrheal disease

Allergen Introduction

  • Current evidence supports early introduction of allergenic foods (peanuts, eggs) at 6 months to reduce sensitization risk (LEAP trial evidence)
  • Do not delay introduction of potentially allergenic foods beyond 12 months

8. Breastfeeding and Lactation

Benefits of Breastfeeding

For Infant:
  • Protective against: otitis media, respiratory infections, UTI, NEC, SIDS, diarrhea
  • Reduces risk of: obesity, type 1 & 2 diabetes, leukemia, asthma, eczema
  • Optimal cognitive development (DHA, human milk oligosaccharides, growth factors)
  • Passive immunity via sIgA, lactoferrin, lysozyme, macrophages, lymphocytes
For Mother:
  • Reduces risk of: breast cancer, ovarian cancer, type 2 diabetes, postpartum hemorrhage (via oxytocin)
  • Lactational amenorrhea method (LAM): family planning if exclusive, amenorrheic, <6 months → 98% effective

Composition of Breast Milk

ComponentColostrum (days 1–3)Mature Milk
ProteinHigh (2.3 g/dL)Lower (0.9 g/dL)
FatLowHigh (~4 g/dL)
IgAVery highModerate
Calories~67 kcal/dL~67 kcal/dL
ColorYellow, thickWhite
  • Foremilk: watery, high lactose — quenches thirst
  • Hindmilk: fat-rich — provides calories; infant must empty breast to receive hindmilk

Lactation Physiology

  • Prolactin: milk production (anterior pituitary); peaks with infant suckling
  • Oxytocin: milk ejection reflex (let-down); released with suckling, skin-to-skin, hearing cry
  • Supply = demand: frequent, effective suckling establishes milk supply

Latch Assessment (LATCH Score)

  • Latch, Audible swallowing, Type of nipple, Comfort, Hold — scored 0–2 each

Contraindications to Breastfeeding

  • Absolute: maternal HIV in resource-rich settings, infant galactosemia, maternal active TB (untreated <2 weeks), maternal HTLV-1/2, maternal herpes simplex lesion on breast
  • Relative/temporary: maternal chemotherapy, certain medications (radioactive isotopes, antineoplastics)
  • Note: CMV in mature breast milk is low-risk for term infants; concern only in VLBW preterms

Common Breastfeeding Problems

  • Engorgement: frequent feeding, warm compress, proper latch
  • Sore nipples: improper latch, Raynaud's phenomenon, candidal infection
  • Mastitis: S. aureus most common; continue breastfeeding + antibiotics (dicloxacillin)
  • Insufficient milk: reassurance, frequent feeding, ensuring effective latch; domperidone/metoclopramide (galactagogues) — use with caution
  • Jaundice: breast milk jaundice (indirect, starts day 7, resolves with continued feeding) vs. breastfeeding failure jaundice (early, improper latch → inadequate intake → dehydration)

9. Cerebral Palsy (CP)

Definition

A group of permanent, non-progressive disorders of movement and posture due to disturbances in the developing fetal or infant brain.

Classification

By Tone/Movement Type:
  • Spastic (most common, ~85%): upper motor neuron lesion, ↑ tone, brisk reflexes, scissor gait
    • Spastic diplegia: predominantly lower limbs (preterm association)
    • Spastic hemiplegia: one side (term, periventricular leukomalacia or MCA stroke)
    • Spastic quadriplegia: all 4 limbs (most severe; associated with intellectual disability, seizures)
  • Dyskinetic/Athetoid: basal ganglia lesion; choreoathetosis; kernicterus association
  • Ataxic: cerebellar; least common; wide-based gait, hypotonia
  • Mixed: most common in practice

Etiology

  • Prenatal (most common ~75%): genetic, congenital brain malformations, TORCH infections, stroke in utero
  • Perinatal: HIE, birth asphyxia, prematurity-related (IVH, PVL), kernicterus
  • Postnatal: meningitis, head trauma, encephalitis (<2–3 years)

Associated Conditions (CAMPS mnemonic — Communication, Associated disorders, Motor, Perception, Seizures)

  • Epilepsy (30–50%), intellectual disability, visual impairment, hearing loss, speech/language disorders, feeding difficulties, scoliosis, hip dysplasia, pain

Diagnosis

  • Clinical: history + neurological exam + developmental assessment
  • MRI brain: most useful (PVL, cortical malformations, basal ganglia lesions) — recommended in all cases
  • Cranial ultrasound: IVH, PVL in preterm
  • EEG if seizures suspected
  • Exclude progressive/metabolic conditions if atypical

Management (Multidisciplinary)

  • Physiotherapy: range of motion, gait training, orthotics
  • Occupational therapy: ADL skills, upper limb function
  • Speech therapy: feeding, communication
  • Spasticity management:
    • Oral: baclofen, diazepam, dantrolene
    • Focal: botulinum toxin A injection (most effective for focal spasticity)
    • Intrathecal baclofen pump (generalized spasticity)
    • Selective dorsal rhizotomy (surgical)
  • Seizure management: anticonvulsants per seizure type
  • Nutrition: high caloric needs, gastrostomy feeding if severe dysphagia
  • Orthopedic surgery: hip reconstruction, tendon lengthening

10. Learning Disorders

Definition

Neurodevelopmental disorders characterized by persistent difficulties in learning academic skills despite adequate instruction, intelligence, and sensory function.

Types (DSM-5)

Dyslexia (reading disorder)
  • Most common learning disorder
  • Impaired reading accuracy, fluency, comprehension
  • Phonological processing deficit (core mechanism)
  • Not due to intellectual disability, visual/hearing impairment, inadequate instruction
  • Associated with ADHD in 40%
Dysgraphia (writing disorder)
  • Impaired written expression: spelling, grammar, punctuation, handwriting
  • Not simply poor penmanship; includes difficulties with written composition
Dyscalculia (mathematics disorder)
  • Difficulty with number sense, arithmetic, and mathematical reasoning
  • Persistent (not explained by instruction or IQ)

ADHD (Attention Deficit Hyperactivity Disorder)

  • Prevalence: 5–10% children
  • Core features: inattention, hyperactivity, impulsivity — present in ≥2 settings, onset before age 12
  • Types: predominantly inattentive, predominantly hyperactive-impulsive, combined
  • Diagnosis: clinical (DSM-5 criteria), no lab or imaging required; behavioral rating scales (Conners, Vanderbilt)
  • Management:
    • First-line medications: methylphenidate (ages 6+), amphetamine salts; stimulants most effective
    • Preschool age (4–5 yrs): behavioral therapy first, methylphenidate if severe
    • Non-stimulants: atomoxetine (SNRI), guanfacine, clonidine
    • School accommodations: extended time, preferential seating, reduced workload

Autism Spectrum Disorder (ASD)

  • Persistent deficits in social communication + restricted, repetitive behaviors
  • Onset in early development; more common in males (4:1)
  • Red flags: no babbling by 12 months, no words by 16 months, no 2-word phrases by 24 months, any regression
  • Screening: M-CHAT-R/F at 18 and 24 months
  • Diagnosis: ADOS-2, ADI-R (gold standard)
  • Management: ABA therapy, speech therapy, OT, social skills training; risperidone/aripiprazole for irritability

Principles of Management (Learning Disorders)

  • Early identification and intervention
  • Individualized education program (IEP) or 504 plan
  • Remediation strategies (phonics-based for dyslexia)
  • Accommodation vs. modification
  • Psychological support for child and family
  • Address comorbidities (anxiety, depression, ADHD)

11. Iron Deficiency Anemia (IDA)

Epidemiology

  • Most common nutritional deficiency and cause of anemia worldwide
  • Peak age: 6 months–3 years (dietary insufficiency after stores deplete) and adolescent girls (menstrual loss)

Stages of Iron Deficiency

  1. Iron depletion: ↓ ferritin (storage iron), normal Hb, normal RBCs
  2. Iron-deficient erythropoiesis: ↓ serum iron, ↑ TIBC, ↓ transferrin saturation, ↑ free erythrocyte protoporphyrin (FEP)
  3. Iron deficiency anemia: microcytic, hypochromic anemia with all above changes

Etiology in Children

  • Inadequate intake: cow's milk excess (>750 mL/day displaces iron-rich foods; low iron content, causes occult GI blood loss), prolonged exclusive breastfeeding without complementary feeding
  • Poor absorption: cow's milk protein intolerance, celiac disease, H. pylori
  • Increased demand: prematurity, low birth weight, twin pregnancy (depleted stores)
  • Blood loss: Meckel's diverticulum, hookworm, inflammatory bowel disease, menorrhagia

Clinical Features

  • Hematological: pallor, easy fatigability, tachycardia, high-output cardiac failure (severe)
  • Non-hematological (pica, neurocognitive impact are key):
    • Pica (eating non-food items)
    • Restless leg syndrome
    • Cognitive impairment, decreased attention, poor school performance (even with mild ID)
    • Spoon-shaped nails (koilonychia), atrophic glossitis, angular stomatitis (severe/chronic)
    • Plummer-Vinson syndrome (web + dysphagia + IDA — rare, adult women)

Laboratory Findings

ParameterIDAFinding
Hemoglobin<11 g/dL (6 mo–5 yr), <11.5 g/dL (5–12 yr)
MCVMicrocytic
MCH, MCHCHypochromic
RDWHigh red cell distribution width
Serum iron
TIBC
Transferrin saturation<15%
Ferritin<12 ng/mL
ReticulocytesAfter iron therapy
Blood smearPencil cells, target cells

Differentiation: IDA vs Thalassemia Trait

FeatureIDABeta-thal trait
RDWNormal
RBC countNormal/↑
Mentzer index (MCV/RBC)>13<13
Hb electrophoresisNormal↑ HbA₂ (>3.5%)
Response to ironYesNo

Treatment

  • Dietary: iron-rich foods (red meat, liver, dark leafy greens, fortified cereals), Vitamin C with meals (enhances absorption), avoid cow's milk >500 mL/day
  • Therapeutic iron:
    • Oral ferrous sulfate: 3–6 mg/kg/day of elemental iron in 2–3 divided doses; given on empty stomach or with Vitamin C
    • Continue for 3 months after normalization of Hb (to replenish stores)
    • Reticulocytosis peaks at 5–10 days; Hb rises 1 g/dL/week
  • IV iron: iron sucrose, ferric carboxymaltose — for malabsorption, intolerance, severe anemia with need for rapid repletion
  • Blood transfusion: Hb <5–7 g/dL with cardiovascular compromise; packed RBCs 10 mL/kg slowly

Prevention

  • Universal supplementation: all infants 4–6 months (breastfed) or formula with ≥12 mg/L iron
  • Preterm/LBW: elemental iron 2 mg/kg/day from 4 weeks of life
  • Delayed cord clamping (≥30–60 seconds): increases iron stores by ~30–40 mg
  • Avoid introduction of cow's milk before 12 months
  • NBS: hemoglobin/ferritin screening at 9–12 months in high-risk

Quick Reference Summary Table

TopicKey Organism/ConditionKey Drug/InterventionCritical Fact
RespiratoryRSV (bronchiolitis)Palivizumab prophylaxisCPAP for RDS; surfactant
NutritionKwashiorkor/MarasmusRUTF, PN100–130 kcal/kg/day (preterm)
MicronutrientsVit D → Rickets400 IU/day (all breastfed)ALP ↑, Vit D ↓
NICURDS, NEC, IVH, ROPCaffeine, surfactant, laser ROPTherapeutic hypothermia for HIE
Growth/DevelopmentMilestonesDenver screeningRegression = always abnormal
ImmunizationBCG, DTP, MMRCold chain 2–8°CVAPP risk with OPV
Complementary feedingIron depletion post-6 moIron-rich foodsNo honey <1 year
BreastfeedingsIgA, lactoferrinGalactagogues PRNLAM 98% effective
Cerebral PalsyHIE, PVL, kernicterusBotulinum toxin, baclofenNon-progressive brain injury
Learning disordersDyslexia (phonological)Methylphenidate (ADHD)M-CHAT at 18 & 24 months
IDACow's milk excess, prematurityFerrous sulfate 3–6 mg/kg/dayMentzer index, treat 3 months post-Hb

This covers all 11 topics in depth from a pediatrics/neonatology perspective. Let me know which topic you'd like to explore further, practice with MCQs, or have condensed into a one-page revision sheet.
This is a shared conversation. Sign in to Orris to start your own chat.